CHEST || News

New agent targets EGFR resistance in NSCLC

Posted on: 29/04/2015 - 22:00

A new agent targeting tumors that develop resistance to EGFR tyrosine kinase inhibitors proved to be “highly active” in a phase I clinical trial i... More »

Field of Interest: Oncology

Type: News Item

Rociletinib active against resistant NSCLC

Posted on: 29/04/2015 - 22:00

Rociletinib, a third-generation EGFR tyrosine kinase inhibitor that targets mutations causing treatment resistance, showed sustained activity against ... More »

Field of Interest: Oncology

Type: News Item

ELCC: NSCLC mutation testing highlights ctDNA’s limitationsvitals

Posted on: 23/04/2015 - 21:46

GENEVA – The tests widely available today that use a cancer patient’s tumor DNA that circulates in the blood to detect a treatment-altering lung c... More »

Field of Interest: Oncology

Type: News Item

ACCP and CTS issue joint guideline on COPD exacerbations

Posted on: 22/04/2015 - 14:59

The American College of Chest Physicians and the Canadian Thoracic Society have issued new recommendations for reducing the risk of acute exacerbation... More »

Field of Interest: Geriatrics

Type: News Item

Palliative surgery eases pain at end of life

Posted on: 06/04/2015 - 17:29

HOUSTON – Palliative surgery can alleviate pain and improve the quality of life for patients dying from advanced cancers, without compromising perfo... More »

Field of Interest: Oncology

Type: News Item

No increased risk of lung disease with methotrexate

Posted on: 02/04/2015 - 17:10

Methotrexate is not associated with an increased risk of pulmonary disease in patients taking it for the treatment of psoriatic arthritis, psoriasis, ... More »

Field of Interest: Rheumatology

Type: News Item

No increased risk of lung disease with methotrexate

Posted on: 02/04/2015 - 17:10

Methotrexate is not associated with an increased risk of pulmonary disease in patients taking it for the treatment of psoriatic arthritis, psoriasis, ... More »

Field of Interest: Dermatology

Type: News Item

No increased risk of lung disease with methotrexate

Posted on: 02/04/2015 - 17:10

Methotrexate is not associated with an increased risk of pulmonary disease in patients taking it for the treatment of psoriatic arthritis, psoriasis, ... More »

Field of Interest: Gastroentero...

Type: News Item

Advanced age no barrier to aggressive heart attack treatment

Posted on: 28/03/2015 - 19:02

SAN DIEGO – Patients aged 80 years and older benefit from more invasive early treatment after non-ST-elevation myocardial infarction or unstable ang... More »

Field of Interest: Geriatrics

Type: News Item

FDA: Avoid using amiodarone with some hepatitis C antivirals

Posted on: 24/03/2015 - 18:12

Taking the antiarrythmic drug amiodarone with the hepatitis C antiviral drugs ledipasvir and sofosbuvir, or with sofosbuvir plus another direct-acting... More »

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters